Trial · NCT03574597
Outcomes29
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
21 to 29 of 29
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Change in High Density Lipoprotein (HDL) Cholesterol - Ratio to Baseline | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | ratio of HDL | GEOMETRIC_MEAN |
| SECONDARY | Change in Low Density Lipoprotein (LDL) Cholesterol - Ratio to Baseline | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | ratio of LDL | GEOMETRIC_MEAN |
| SECONDARY | Change in Triglycerides - Ratio to Baseline | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | ratio of triglycerides | GEOMETRIC_MEAN |
| SECONDARY | Change in Body Weight | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | percentage change in body weight | MEAN |
| SECONDARY | Change in Waist Circumference | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | centimeter (cm) | MEAN |
| SECONDARY | Change From Randomisation (Week 0) in Participant Reported Outcome (PRO): EuroQol Five Dimensions Five Level Questionnaire (EQ-5D-5L) Index Score to Week 104 | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | score on a scale | MEAN |
| SECONDARY | Change From Randomisation (Week 0) in PRO: EuroQol Five Dimensions Visual Analogue Scale (EQ-5D-VAS) to Week 104 | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | score on a scale | MEAN |
| SECONDARY | Change in HbA1c - Percentage | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | Percentage of HbA1c | MEAN |
| SECONDARY | Change in HbA1c - mmol/Mol | Week 0, week 104 | FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation. Here, overall number of participants analyzed = number of participants who contributed to the analysis. | mmol/mol | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03574597/outcomes?page=2